Osteoblast-Derived Matrix Vesicles Exhibit Exosomal Traits and a Unique Subset of microRNA: Their Caveolae-Dependent Endocytosis Results in Reduced Osteogenic Differentiation.
caveolin
differentiation
endocytosis
extracellular vesicles
matrix vesicles
microRNA
osteoblasts
osteogenesis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Aug 2023
14 Aug 2023
Historique:
received:
19
06
2023
revised:
08
08
2023
accepted:
11
08
2023
medline:
28
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Matrix vesicles (MVs) are nano-sized extracellular vesicles that are anchored in the extracellular matrix (ECM). In addition to playing a role in biomineralization, osteoblast-derived MVs were recently suggested to have regulatory duties. The aims of this study were to establish the characteristics of osteoblast-derived MVs in the context of extracellular vesicles like exosomes, assess their role in modulating osteoblast differentiation, and examine their mechanism of uptake. MVs were isolated from the ECM of MG63 human osteoblast-like cell cultures and characterized via enzyme activity, transmission electron microscopy, nanoparticle tracking analysis, Western blot, and small RNA sequencing. Osteoblasts were treated with MVs from two different culture conditions (growth media [GM]; osteogenic media [OM]) to evaluate their effects on the differentiation and production of inflammatory markers and on macrophage polarization. MV endocytosis was assessed using a lipophilic, fluorescent dye and confocal microscopy with the role of caveolae determined using methyl-β-cyclodextrin. MVs exhibited a four-fold enrichment in alkaline phosphatase specific activity compared to plasma membranes; were 50-150 nm in diameter; possessed exosomal markers CD63, CD81, and CD9 and endosomal markers ALIX, TSG101, and HSP70; and were selectively enriched in microRNA linked to an anti-osteogenic effect and to M2 macrophage polarization. Treatment with GM or OM MVs decreased osteoblast differentiation. Osteoblasts endocytosed MVs using a mechanism that involves caveolae. These results support the hypothesis that osteoblasts produce MVs that participate in the regulation of osteogenesis.
Identifiants
pubmed: 37628952
pii: ijms241612770
doi: 10.3390/ijms241612770
pmc: PMC10454939
pii:
doi:
Substances chimiques
MicroRNAs
0
Culture Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : R01AR072500
Pays : United States
Références
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):2893-2901
pubmed: 32271407
Cancer Lett. 2015 Aug 1;364(1):59-69
pubmed: 25933830
Connect Tissue Res. 1990;24(1):67-75
pubmed: 2338026
Front Immunol. 2020 Jul 03;11:1391
pubmed: 32719678
Bone. 1988;9(3):185-94
pubmed: 3166834
J Cell Biol. 2012 May 14;197(4):509-21
pubmed: 22564414
BMB Rep. 2020 Apr;53(4):223-228
pubmed: 31964468
Cell Mol Biol Lett. 2023 Jan 30;28(1):9
pubmed: 36717768
Eur Cell Mater. 2012 Jul 09;24:1-17
pubmed: 22777949
Sci Rep. 2018 Feb 26;8(1):3609
pubmed: 29483516
Clin Sci (Lond). 2019 Sep 19;133(18):1955-1975
pubmed: 31387936
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):519-526
pubmed: 27900532
J Bone Miner Metab. 2008;26(5):514-9
pubmed: 18758911
Annu Rev Biochem. 2009;78:857-902
pubmed: 19317650
Bone. 2020 Aug;137:115444
pubmed: 32447074
Stem Cell Res Ther. 2022 Apr 8;13(1):149
pubmed: 35395782
FEBS Lett. 2016 Jan;590(1):185-92
pubmed: 26763102
Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):532-546
pubmed: 29108957
Oncotarget. 2016 Jan 5;7(1):7-22
pubmed: 26683705
Cell Tissue Res. 2022 May;388(2):301-312
pubmed: 35192037
Methods Mol Biol. 2022;2455:333-341
pubmed: 35213005
Biomater Sci. 2017 Dec 19;6(1):60-78
pubmed: 29184934
J Oral Biosci. 2020 Sep;62(3):228-234
pubmed: 32535286
Oncology. 1978;35(6):246-52
pubmed: 218153
Curr Pharm Des. 2019;25(45):4806-4812
pubmed: 31566128
Circulation. 2013 Apr 16;127(15):1609-19
pubmed: 23513069
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207
pubmed: 29074454
Am J Transl Res. 2020 May 15;12(5):2062-2070
pubmed: 32509200
Commun Biol. 2020 Jan 16;3(1):30
pubmed: 31949279
J Bone Miner Metab. 2017 May;35(3):255-264
pubmed: 27085967
Semin Liver Dis. 2015 Feb;35(1):3-11
pubmed: 25632930
Physiol Rep. 2017 Feb;5(4):
pubmed: 28235973
Elife. 2019 Sep 04;8:
pubmed: 31482845
J Dent (Shiraz). 2023 Jun;24(2):235-244
pubmed: 37388198
J Control Release. 2017 Nov 28;266:100-108
pubmed: 28919558
Calcif Tissue Int. 2021 Oct;109(4):455-468
pubmed: 33950267
Cell Biochem Biophys. 2015 Jan;71(1):255-60
pubmed: 25241081
Bone Miner. 1992 May;17(2):139-44
pubmed: 1611299
Bone. 2016 Jul;88:47-55
pubmed: 27080510
Front Genet. 2019 Jan 22;9:636
pubmed: 30723492
Int J Mol Sci. 2021 Feb 23;22(4):
pubmed: 33672100
PLoS One. 2014 Apr 14;9(4):e94997
pubmed: 24733347
Biomed Pharmacother. 2019 Dec;120:109378
pubmed: 31541885
Regen Med. 2021 May;16(5):435-449
pubmed: 34000812
Int J Mol Med. 2018 Mar;41(3):1536-1546
pubmed: 29328414
Bone Rep. 2022 Oct 18;17:101627
pubmed: 36304905
Gels. 2023 Jul 10;9(7):
pubmed: 37504441
J Biol Chem. 2013 Jun 14;288(24):17713-24
pubmed: 23653359
PLoS One. 2017 Nov 22;12(11):e0188530
pubmed: 29166412
Anat Rec. 1989 Jun;224(2):211-9
pubmed: 2672885
Stem Cell Res Ther. 2020 Dec 9;11(1):531
pubmed: 33298186
J Cell Physiol. 2018 Sep;233(9):6425-6440
pubmed: 29319160
Front Biosci. 2005 Jan 01;10:822-37
pubmed: 15569622
Gut. 2022 Aug;71(8):1642-1655
pubmed: 34706869
Calcif Tissue Int. 1994 May;54(5):399-408
pubmed: 8062158
J Biol Chem. 1994 Nov 11;269(45):28374-81
pubmed: 7961777
J Neuroinflammation. 2020 Aug 20;17(1):244
pubmed: 32819407
J Biol Chem. 1969 Jul 10;244(13):3561-9
pubmed: 4240115
Hum Cell. 2023 May;36(3):1041-1053
pubmed: 36952210
Cell Immunol. 2021 Jul;365:104377
pubmed: 34004369
J Nanobiotechnology. 2022 Jan 20;20(1):38
pubmed: 35057811
Mol Ther Nucleic Acids. 2020 Mar 6;19:619-626
pubmed: 31945725
Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20794-9
pubmed: 19933329
Front Biosci (Landmark Ed). 2012 Jan 01;17(1):100-28
pubmed: 22201735
Steroids. 2019 Feb;142:43-47
pubmed: 29233620
Int Immunopharmacol. 2021 Oct;99:108006
pubmed: 34339965
J Bone Miner Res. 2006 Oct;21(10):1637-47
pubmed: 16995819
Front Immunol. 2022 Sep 21;13:974332
pubmed: 36211336
ACS Appl Mater Interfaces. 2018 Feb 14;10(6):5240-5254
pubmed: 29359912
Bone. 2015 Oct;79:29-36
pubmed: 25980744
Curr Osteoporos Rep. 2017 Feb;15(1):24-31
pubmed: 28181063
Biosci Rep. 2019 Mar 26;39(3):
pubmed: 30804229
J Bone Miner Res. 2021 Sep;36(9):1808-1822
pubmed: 34004029
Bone. 2018 Dec;117:98-115
pubmed: 30218791
Sci Rep. 2016 Feb 25;6:21961
pubmed: 26911789
J Transl Med. 2021 Apr 16;19(1):140
pubmed: 33858417
J Biol Chem. 2002 Apr 5;277(14):11828-37
pubmed: 11805100
Histochem Cell Biol. 2018 Apr;149(4):289-304
pubmed: 29411103
Calcif Tissue Int. 1996 Aug;59(2):109-16
pubmed: 8687979
J Bone Miner Res. 1995 Nov;10(11):1614-24
pubmed: 8592937
Oncotarget. 2017 Sep 18;8(52):89913-89922
pubmed: 29163798
Gen Physiol Biophys. 2021 Jul;40(4):329-339
pubmed: 34350837
Oncol Rep. 2019 Aug;42(2):581-594
pubmed: 31233191
Adv Dent Res. 1999 Jun;13:38-48
pubmed: 11276745
J Biol Chem. 2014 Aug 8;289(32):22258-67
pubmed: 24951588
J Extracell Vesicles. 2022 Jun;11(6):e12228
pubmed: 35656866
Gene. 2017 Sep 5;627:32-39
pubmed: 28587848
Immunol Cell Biol. 2020 Oct;98(9):715-725
pubmed: 32524675
Biomed Pharmacother. 2017 May;89:1178-1186
pubmed: 28320084
Oncol Lett. 2019 Dec;18(6):6339-6346
pubmed: 31788111
J Tissue Eng. 2018 Nov 02;9:2041731418810130
pubmed: 30450187
J Biomed Mater Res. 1995 Mar;29(3):389-401
pubmed: 7542245
Cell Death Discov. 2021 Feb 24;7(1):37
pubmed: 33627637
Front Immunol. 2017 Oct 16;8:1327
pubmed: 29085372
Life Sci. 2013 Mar 21;92(10):562-8
pubmed: 23353875
Calcif Tissue Int. 1997 Oct;61(4):313-21
pubmed: 9312202
Biomed Pharmacother. 2022 Sep;153:113463
pubmed: 36076572
PLoS One. 2023 Apr 7;18(4):e0284258
pubmed: 37027385